FDMT 4D MOLECULAR THERAPEUTICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Tue 10 Nov 2026 · estimated
What 15 analyst firms say about 4D MOLECULAR THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
15 rated views · 16 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8078
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8057
Recent analyst activity · last 90 days
Our tracked history has 9 reports on FDMT from 9 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 3 left it unchanged and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Mayank Mamtani | Buy | 17 Aug 2026 | — |
| Bank of America Securities | Tazeen Ahmad | Buy | 29 Sep 2026 | 33.00 USD |
| Barclays | Eliana Merle | Buy | 24 Jun 2026 | 33.00 USD |
| Barclays | Gena Wang | Buy | 28 Jan 2026 | 33.00 USD |
| Cantor Fitzgerald | Josh Schimmer | Buy | 14 Sep 2026 | 20.00 USD |
| Chardan Capital Markets | Gautam Chukka | Buy | 6 Oct 2026 | 25.00 USD |
| Citigroup | Unnamed analyst | Buy | 22 Oct 2026 | — |
| Evercore ISI | Jonathan Miller | Buy | 10 Apr 2026 | 23.00 USD |
| Goldman Sachs | Salveen Richter | Buy | 13 Aug 2026 | 32.00 USD |
| H.C. Wainwright | Matthew Caufield | Buy | 22 Oct 2026 | 36.00 USD |
| Jefferies | Faisal Khurshid | Buy | 30 Mar 2026 | Conflicting reports · excluded |
| Leerink Partners | Lili Nsongo | Buy | 6 Jul 2026 | 18.00 USD |
| Morgan Stanley | Unnamed analyst | Hold | 7 Nov 2025 | — |
| RBC Capital Markets | Lisa Walter | Buy | 14 Aug 2026 | 35.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:14 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.